We sit down with Hanns-Christian Mahler, CEO of ten23 health.

UK-based center will have capacity for RNA therapeutic production for clinical trials and potential future health emergencies.

With new drugs showing promise for Alzheimer’s, is the drug development drought over?

A look at cGMP deviations in recent warning letters, including manufacturing conducted in corridors and equipment uncleaned for 14 years.

Why one company is focusing on camelid-derived antibodies to tackle dengue.

Nominations are open now – but only until October 10.

What lies ahead for biopharma manufacturers when it comes to downstream analytical tech?

The pharma giant’s COVID-19 vaccine saved millions of lives, but the company is quickly falling from grace.

Who are the most influential and inspirational people in drug development and manufacturing? Nominations for the Power List 2024 are now open!

I explore recent cases of pediatric cough medicines contaminated with diethylene glycol.